Acuña, Arjelyn A.
HRN: 03-91-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2025
CEFUROXIME 500MG (TAB)
10/19/2025
10/24/2025
PO
500mg
BID
NSVD (Non-institutional Delivery)
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes